Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Kernel-Based Microfluidic Constriction Assay for Tumor Sample Identification.

Ren X, Ghassemi P, Kanaan YM, Naab T, Copeland RL, Dewitty RL, Kim I, Strobl JS, Agah M.

ACS Sens. 2018 Jul 18. doi: 10.1021/acssensors.8b00301. [Epub ahead of print]

PMID:
29979037
2.

Entrapment of Prostate Cancer Circulating Tumor Cells with a Sequential Size-Based Microfluidic Chip.

Ren X, Foster BM, Ghassemi P, Strobl JS, Kerr BA, Agah M.

Anal Chem. 2018 Jun 19;90(12):7526-7534. doi: 10.1021/acs.analchem.8b01134. Epub 2018 Jun 1.

PMID:
29790741
3.

Microfluidic Iterative Mechanical Characteristics (iMECH) Analyzer for Single-Cell Metastatic Identification.

Babahosseini H, Strobl JS, Agah M.

Anal Methods. 2017 Feb 7;9(5):847-855. doi: 10.1039/C6AY03342C. Epub 2017 Jan 4.

4.

Single-Cell Mechanical Characteristics Analyzed by Multiconstriction Microfluidic Channels.

Ren X, Ghassemi P, Babahosseini H, Strobl JS, Agah M.

ACS Sens. 2017 Feb 24;2(2):290-299. doi: 10.1021/acssensors.6b00823. Epub 2017 Feb 10.

5.

The impact of sphingosine kinase inhibitor-loaded nanoparticles on bioelectrical and biomechanical properties of cancer cells.

Babahosseini H, Srinivasaraghavan V, Zhao Z, Gillam F, Childress E, Strobl JS, Santos WL, Zhang C, Agah M.

Lab Chip. 2016 Jan 7;16(1):188-98. doi: 10.1039/c5lc01201e. Epub 2015 Nov 26.

6.

Using nanotechnology and microfluidics in search of cell biomechanical cues for cancer progression.

Babahosseini H, Strobl JS, Agah M.

Nanomedicine (Lond). 2015;10(17):2635-8. doi: 10.2217/nnm.15.104. Epub 2015 Sep 2. No abstract available.

7.

Single cell metastatic phenotyping using pulsed nanomechanical indentations.

Babahosseini H, Strobl JS, Agah M.

Nanotechnology. 2015 Sep 4;26(35):354004. doi: 10.1088/0957-4484/26/35/354004. Epub 2015 Aug 12.

PMID:
26266760
8.

Sub-cellular force microscopy in single normal and cancer cells.

Babahosseini H, Carmichael B, Strobl JS, Mahmoodi SN, Agah M.

Biochem Biophys Res Commun. 2015 Aug 7;463(4):587-92. doi: 10.1016/j.bbrc.2015.05.100. Epub 2015 May 31.

PMID:
26036579
9.

Efficacy of decoquinate against Sarcocystis neurona in cell cultures.

Lindsay DS, Nazir MM, Maqbool A, Ellison SP, Strobl JS.

Vet Parasitol. 2013 Sep 1;196(1-2):21-3. doi: 10.1016/j.vetpar.2013.02.008. Epub 2013 Feb 21.

PMID:
23523012
10.

Dopamine stimulates propagation of Toxoplasma gondii tachyzoites in human fibroblast and primary neonatal rat astrocyte cell cultures.

Strobl JS, Goodwin DG, Rzigalinski BA, Lindsay DS.

J Parasitol. 2012 Dec;98(6):1296-9. doi: 10.1645/GE-2760.1. Epub 2012 Apr 18.

PMID:
22512377
11.

Congenital infection of mice with Toxoplasma gondii induces minimal change in behavior and no change in neurotransmitter concentrations.

Goodwin D, Hrubec TC, Klein BG, Strobl JS, Werre SR, Han Q, Zajac AM, Lindsay DS.

J Parasitol. 2012 Aug;98(4):706-12. doi: 10.1645/GE-3068.1. Epub 2012 Apr 2.

PMID:
22468990
12.

MCF10A and MDA-MB-231 human breast basal epithelial cell co-culture in silicon micro-arrays.

Nikkhah M, Strobl JS, Schmelz EM, Roberts PC, Zhou H, Agah M.

Biomaterials. 2011 Oct;32(30):7625-32. doi: 10.1016/j.biomaterials.2011.06.041. Epub 2011 Jul 18.

PMID:
21764441
13.

Evaluation of five antischizophrenic agents against Toxoplasma gondii in human cell cultures.

Goodwin DG, Strobl JS, Lindsay DS.

J Parasitol. 2011 Feb;97(1):148-51. doi: 10.1645/GE-2536.1. Epub 2010 Sep 14.

PMID:
21348624
14.

Evaluation of the influence of growth medium composition on cell elasticity.

Nikkhah M, Strobl JS, Schmelz EM, Agah M.

J Biomech. 2011 Feb 24;44(4):762-6. doi: 10.1016/j.jbiomech.2010.11.002. Epub 2010 Nov 24.

PMID:
21109247
15.

Actions of the anti-cancer drug suberoylanilide hydroxamic acid (SAHA) on human breast cancer cytoarchitecture in silicon microstructures.

Strobl JS, Nikkhah M, Agah M.

Biomaterials. 2010 Sep;31(27):7043-50. doi: 10.1016/j.biomaterials.2010.05.023. Epub 2010 Jun 25.

PMID:
20579727
16.

The cytoskeletal organization of breast carcinoma and fibroblast cells inside three dimensional (3-D) isotropic silicon microstructures.

Nikkhah M, Strobl JS, De Vita R, Agah M.

Biomaterials. 2010 Jun;31(16):4552-61. doi: 10.1016/j.biomaterials.2010.02.034. Epub 2010 Mar 6.

PMID:
20207413
17.

Method to quantify the effect of passivation layer in bio-impedance sensors.

Narayanan S, Nikkhah M, Strobl JS, Agah M.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:3783-6. doi: 10.1109/IEMBS.2009.5334389.

PMID:
19964816
18.

Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.

Rahim R, Strobl JS.

Anticancer Drugs. 2009 Sep;20(8):736-45. doi: 10.1097/CAD.0b013e32832f4e50.

PMID:
19584707
19.

Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots.

Rzigalinski BA, Strobl JS.

Toxicol Appl Pharmacol. 2009 Aug 1;238(3):280-8. doi: 10.1016/j.taap.2009.04.010. Epub 2009 Apr 18. Review.

20.

Cytoskeletal role in differential adhesion patterns of normal fibroblasts and breast cancer cells inside silicon microenvironments.

Nikkhah M, Strobl JS, Peddi B, Agah M.

Biomed Microdevices. 2009 Jun;11(3):585-95. doi: 10.1007/s10544-008-9268-2.

PMID:
19089620
21.

Attachment and response of human fibroblast and breast cancer cells to three dimensional silicon microstructures of different geometries.

Nikkhah M, Strobl JS, Agah M.

Biomed Microdevices. 2009 Apr;11(2):429-41. doi: 10.1007/s10544-008-9249-5.

PMID:
19058013
22.

Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent.

Strobl JS, Seibert CW, Li Y, Nagarkatti R, Mitchell SM, Rosypal AC, Rathore D, Lindsay DS.

J Parasitol. 2009 Feb;95(1):215-23. doi: 10.1645/GE-1608.1.

PMID:
18837587
23.

Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against oxidative and electrophilic stress.

Zhu H, Jia Z, Strobl JS, Ehrich M, Misra HP, Li Y.

Cardiovasc Toxicol. 2008 Fall;8(3):115-25. doi: 10.1007/s12012-008-9020-4. Epub 2008 Jul 8.

PMID:
18607771
24.

Geometry-dependent behavior of fibroblast cells in three-dimensional silicon microstructures.

Nikkhah M, Strobl JS, Agah M.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:6078-81.

PMID:
18003401
25.

Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.

Strobl JS, Cassell M, Mitchell SM, Reilly CM, Lindsay DS.

J Parasitol. 2007 Jun;93(3):694-700.

PMID:
17626366
26.

Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human breast cancer cell model.

Martirosyan AR, Rahim-Bata R, Freeman AB, Clarke CD, Howard RL, Strobl JS.

Biochem Pharmacol. 2004 Nov 1;68(9):1729-38.

PMID:
15450938
27.

Molecular and cellular determinants of estrogen receptor alpha expression.

Pinzone JJ, Stevenson H, Strobl JS, Berg PE.

Mol Cell Biol. 2004 Jun;24(11):4605-12. Review. No abstract available.

28.

Design, synthesis, and bioactivities of steroid-linked taxol analogues as potential targeted drugs for prostate and breast cancer.

Liu C, Strobl JS, Bane S, Schilling JK, McCracken M, Chatterjee SK, Rahim-Bata R, Kingston DG.

J Nat Prod. 2004 Feb;67(2):152-9.

PMID:
14987051
29.

Protein kinase C delta is a prosurvival factor in human breast tumor cell lines.

McCracken MA, Miraglia LJ, McKay RA, Strobl JS.

Mol Cancer Ther. 2003 Mar;2(3):273-81.

30.

Myc protein is differentially sensitive to quinidine in tumor versus immortalized breast epithelial cell lines.

Melkoumian ZK, Martirosyan AR, Strobl JS.

Int J Cancer. 2002 Nov 1;102(1):60-9.

31.

Control of mammary tumor cell growth in vitro by novel cell differentiation and apoptosis agents.

Zhou Q, McCracken MA, Strobl JS.

Breast Cancer Res Treat. 2002 Sep;75(2):107-17.

PMID:
12243503
32.

Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1.

Zhou Q, Melkoumian ZK, Lucktong A, Moniwa M, Davie JR, Strobl JS.

J Biol Chem. 2000 Nov 10;275(45):35256-63.

33.

The cell death response to gamma-radiation in MCF-7 cells is enhanced by a neuroleptic drug, pimozide.

Strobl JS, Melkoumian Z, Peterson VA, Hylton H.

Breast Cancer Res Treat. 1998 Sep;51(1):83-95.

PMID:
9877031
34.

Evidence for an early G1 ionic event necessary for cell cycle progression and survival in the MCF-7 human breast carcinoma cell line.

Wang S, Melkoumian Z, Woodfork KA, Cather C, Davidson AG, Wonderlin WF, Strobl JS.

J Cell Physiol. 1998 Sep;176(3):456-64.

PMID:
9699498
35.

A sequence in the 5' flanking region confers progestin responsiveness on the human c-myc gene.

Moore MR, Zhou JL, Blankenship KA, Strobl JS, Edwards DP, Gentry RN.

J Steroid Biochem Mol Biol. 1997 Jul;62(4):243-52.

PMID:
9408078
36.

Potassium channels, proliferation and G1 progression.

Wonderlin WF, Strobl JS.

J Membr Biol. 1996 Nov;154(2):91-107. Review. No abstract available.

PMID:
8929284
37.

Mitogenic signal transduction in human breast cancer cells.

Strobl JS, Wonderlin WF, Flynn DC.

Gen Pharmacol. 1995 Dec;26(8):1643-9. Review.

PMID:
8745151
38.

Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle.

Wonderlin WF, Woodfork KA, Strobl JS.

J Cell Physiol. 1995 Oct;165(1):177-85.

PMID:
7559799
39.

Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture.

Woodfork KA, Wonderlin WF, Peterson VA, Strobl JS.

J Cell Physiol. 1995 Feb;162(2):163-71.

PMID:
7822427
40.

A survey of human breast cancer sensitivity to growth inhibition by calmodulin antagonists in tissue culture.

Strobl JS, Peterson VA, Woodfork KA.

Biochem Pharmacol. 1994 Jun 15;47(12):2157-61.

PMID:
8031308
41.

Human growth hormone.

Strobl JS, Thomas MJ.

Pharmacol Rev. 1994 Mar;46(1):1-34. Review.

PMID:
8190748
42.

Regulation of rat growth hormone gene expression in tissue culture: influence of cell growth phase.

Matamoros MC, Van Dyke K, Strobl JS.

Biochem Mol Biol Int. 1993 Feb;29(2):213-20.

PMID:
8495207
43.
44.

Z-DNA formation in the rat growth hormone gene promoter region.

Thomas MJ, Freeland TM, Strobl JS.

Mol Cell Biol. 1990 Oct;10(10):5378-87.

45.

Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine.

Strobl JS, Kirkwood KL, Lantz TK, Lewine MA, Peterson VA, Worley JF 3rd.

Cancer Res. 1990 Sep 1;50(17):5399-405.

46.

A role for DNA methylation in vertebrate gene expression?

Strobl JS.

Mol Endocrinol. 1990 Feb;4(2):181-3. Review. No abstract available.

PMID:
2184348
47.
48.

Inhibition of rat growth hormone promoter activity by site-specific DNA methylation.

Gaido ML, Strobl JS.

Biochim Biophys Acta. 1989 Jul 7;1008(2):234-42.

PMID:
2544228
49.

Enzyme-linked immunosorbent assays for Z-DNA.

Thomas MJ, Strobl JS.

Biochem J. 1988 Oct 1;255(1):53-9.

50.

Supplemental Content

Loading ...
Support Center